[{"@_fa": "true", "load-date": "2019-04-16T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0618827819304098"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0618827819304098?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0618-8278(19)30409-8", "prism:url": "https://api.elsevier.com/content/article/pii/S0618827819304098", "dc:title": "THU-134-Clinical and virological characteristics of patients with chronic hepatitis C and failure to voxilaprevir/velpatasvir/sofosbuvir treatment", "dc:creator": "Julia Dietz", "prism:publicationName": "Journal of Hepatology", "prism:volume": "70", "prism:coverDate": "2019-04-30", "prism:startingPage": "e219", "prism:endingPage": "e220", "prism:doi": "10.1016/S0618-8278(19)30409-8", "openaccess": false, "pii": "S0618827819304098", "authors": {"author": [{"$": "Julia Dietz"}, {"$": "Adolfo de Salazar"}, {"$": "Christoph Sarrazin"}]}}, {"@_fa": "true", "load-date": "2020-08-25T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S1473050220302366"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S1473050220302366?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/j.transci.2020.102922", "prism:url": "https://api.elsevier.com/content/article/pii/S1473050220302366", "dc:title": "SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma", "dc:creator": "Latha Dulipsingh", "prism:publicationName": "Transfusion and Apheresis Science", "prism:volume": "59", "prism:coverDate": "2020-12-31", "prism:startingPage": "102922", "prism:doi": "10.1016/j.transci.2020.102922", "openaccess": false, "pii": "S1473050220302366", "authors": {"author": [{"$": "Latha Dulipsingh"}, {"$": "Danyal Ibrahim"}, {"$": "Syed A. Hussain"}]}}, {"@_fa": "true", "load-date": "2019-05-29T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S1665268119304107"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S1665268119304107?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.5604/01.3001.0009.8592", "prism:url": "https://api.elsevier.com/content/article/pii/S1665268119304107", "dc:title": "Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant", "dc:creator": "Eric M. Yoshida", "prism:publicationName": "Annals of Hepatology", "prism:volume": "16", "prism:coverDate": "2017-06-30", "prism:startingPage": "375", "prism:endingPage": "381", "prism:doi": "10.5604/01.3001.0009.8592", "openaccess": true, "pii": "S1665268119304107", "authors": {"author": [{"$": "Eric M. Yoshida"}, {"$": "Paul Kwo"}, {"$": "Beat M\u00fcllhaupt"}]}}, {"@_fa": "true", "load-date": "2018-06-12T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0041134518302136"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0041134518302136?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/j.transproceed.2018.02.062", "prism:url": "https://api.elsevier.com/content/article/pii/S0041134518302136", "dc:title": "Safety of Direct-Acting Antiviral Therapy Regarding Renal Function in Post\u2013Liver Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response\u2014A Single-Center Study", "dc:creator": "G. Peschel", "prism:publicationName": "Transplantation Proceedings", "prism:volume": "50", "prism:coverDate": "2018-06-30", "prism:startingPage": "1444", "prism:endingPage": "1450", "prism:doi": "10.1016/j.transproceed.2018.02.062", "openaccess": false, "pii": "S0041134518302136", "authors": {"author": [{"$": "G. Peschel"}, {"$": "L. Moleda"}, {"$": "K. Weigand"}]}}, {"@_fa": "true", "load-date": "2018-04-23T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827818313163"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827818313163?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(18)31316-3", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827818313163", "dc:title": "FRI-376: Resolution of clinically significant portal hypertension after sustained virologic response to interferon-free regimens prevents hepatic decompensation", "dc:creator": "M. Mandorfer", "prism:publicationName": "Journal of Hepatology", "prism:volume": "68", "prism:coverDate": "2018-04-30", "prism:startingPage": "s532", "prism:doi": "10.1016/S0168-8278(18)31316-3", "openaccess": false, "pii": "S0168827818313163", "authors": {"author": [{"$": "M. Mandorfer"}, {"$": "K. Kozbial"}, {"$": "T. Reiberger"}]}}, {"@_fa": "true", "load-date": "2018-03-08T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0016508518301501"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0016508518301501?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1053/j.gastro.2017.08.078", "prism:url": "https://api.elsevier.com/content/article/pii/S0016508518301501", "dc:title": "Monitoring the Evolution of Portal Hypertension After Sustained Virologic Response", "dc:creator": "Mattias Mandorfer", "prism:publicationName": "Gastroenterology", "prism:volume": "154", "prism:coverDate": "2018-04-30", "prism:startingPage": "1550", "prism:endingPage": "1551", "prism:doi": "10.1053/j.gastro.2017.08.078", "openaccess": false, "pii": "S0016508518301501", "authors": {"author": [{"$": "Mattias Mandorfer"}, {"$": "Thomas Reiberger"}, {"$": "Markus Peck-Radosavljevic"}]}}, {"@_fa": "true", "load-date": "2018-04-23T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827818312613"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827818312613?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(18)31261-3", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827818312613", "dc:title": "FRI-321: A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study", "dc:creator": "A. Wranke", "prism:publicationName": "Journal of Hepatology", "prism:volume": "68", "prism:coverDate": "2018-04-30", "prism:startingPage": "s507", "prism:doi": "10.1016/S0168-8278(18)31261-3", "openaccess": false, "pii": "S0168827818312613", "authors": {"author": [{"$": "A. Wranke"}, {"$": "C. Yurdaydin"}, {"$": "S. Hardtke"}]}}, {"@_fa": "true", "load-date": "2016-07-25T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827816303439"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827816303439?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/j.jhep.2016.07.018", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827816303439", "dc:title": "Reply to: \u201cHCV RNA kinetics on-treatment do not predict sustained virologic response in HCV genotype 3 patients receiving sofosbuvir and ribavirin\u201d", "dc:creator": "Benjamin Maasoumy", "prism:publicationName": "Journal of Hepatology", "prism:volume": "65", "prism:coverDate": "2016-11-30", "prism:startingPage": "1059", "prism:endingPage": "1060", "prism:doi": "10.1016/j.jhep.2016.07.018", "openaccess": false, "pii": "S0168827816303439", "authors": {"author": [{"$": "Benjamin Maasoumy"}, {"$": "Johannes Vermehren"}, {"$": "Christoph Sarrazin"}]}}, {"@_fa": "true", "load-date": "2012-04-23T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827812605613"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827812605613?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(12)60561-3", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827812605613", "dc:title": "548 UNEXPECTED INCREASE OF HEPATITIS B SURFACE ANTIGEN (HBSAG) CONCENTRATIONS DURING TREATMENT WITH NUCLEOS(T)IDE ANALOGUES 12-24 MONTHS BEFORE VIROLOGICAL BREAKTHROUGH AND RESISTANCE", "dc:creator": "S. B. Wiegand", "prism:publicationName": "Journal of Hepatology", "prism:volume": "56", "prism:coverDate": "2012-04-30", "prism:startingPage": "s217", "prism:doi": "10.1016/S0168-8278(12)60561-3", "openaccess": false, "pii": "S0168827812605613", "authors": {"author": [{"$": "S. B. Wiegand"}, {"$": "J. Jaroszewicz"}, {"$": "M. Cornberg"}]}}, {"@_fa": "true", "load-date": "2011-04-18T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827811604066"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827811604066?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(11)60406-6", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827811604066", "dc:title": "404 DOSE REDUCTION OF PEGINTERFERON ALFA-2A (PEG) IN COMBINATION WITH RIBAVIRIN (RBV) IN CHRONIC HEPATITIS C (CHC) PATIENTS: IMPACT ON VIROLOGICAL RESPONSE UNDER REAL LIFE CONDITIONS", "dc:creator": "K. Boeker", "prism:publicationName": "Journal of Hepatology", "prism:volume": "54", "prism:coverDate": "2011-03-31", "prism:startingPage": "s162", "prism:doi": "10.1016/S0168-8278(11)60406-6", "openaccess": false, "pii": "S0168827811604066", "authors": {"author": [{"$": "K. Boeker"}, {"$": "S. Mauss"}, {"$": "E. Zehnter"}]}}, {"@_fa": "true", "load-date": "2014-04-24T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827814612885"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827814612885?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(14)61288-5", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827814612885", "dc:title": "P1128 A MODEL TO ESTIMATE <ce:italic>A PRIORI</ce:italic> THE PROBABILITY OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-INTERFERON AND RIBAVIRIN FOR PATIENTS WITH HCV-1 INFECTION", "dc:creator": "A. Andriulli", "prism:publicationName": "Journal of Hepatology", "prism:volume": "60", "prism:coverDate": "2014-04-30", "prism:startingPage": "s456", "prism:doi": "10.1016/S0168-8278(14)61288-5", "openaccess": false, "pii": "S0168827814612885", "authors": {"author": [{"$": "A. Andriulli"}, {"$": "M. Angelico"}, {"$": "A. Crax\u00ec"}]}}, {"@_fa": "true", "load-date": "2010-04-13T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827810600268"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827810600268?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(10)60026-8", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827810600268", "dc:title": "24 HIGHER SUSTAINED VIROLOGIC RESPONSE AND HISTOLOGIC IMPROVEMENT IN RECURRENT HEPATITIS C AFTER PEGYLATED INTERFERON PLUS RIBAVIRIN THERAPY UNDER CYCLOSPORINE-BASED VERSUS TACROLIMUS-BASED IMMUNOSUPPRESSIVE THERAPY", "dc:creator": "M. Navasa", "prism:publicationName": "Journal of Hepatology", "prism:volume": "52", "prism:coverDate": "2010-04-30", "prism:startingPage": "s11", "prism:doi": "10.1016/S0168-8278(10)60026-8", "openaccess": false, "pii": "S0168827810600268", "authors": {"author": [{"$": "M. Navasa"}, {"$": "T. Casanovas"}, {"$": "M. Guilera"}]}}, {"@_fa": "true", "load-date": "2011-04-18T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827811608222"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827811608222?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(11)60822-2", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827811608222", "dc:title": "820 CD81 EXPRESSION ON LYMPHOCYTE SUBTYPES FOR DISCRIMINATION BETWEEN SUSTAINED VIROLOGIC RESPONSE AND RELAPSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEG-INTERFERON-ALFA AND RIBAVIRIN", "dc:creator": "M. Welker", "prism:publicationName": "Journal of Hepatology", "prism:volume": "54", "prism:coverDate": "2011-03-31", "prism:startingPage": "s328", "prism:endingPage": "s329", "prism:doi": "10.1016/S0168-8278(11)60822-2", "openaccess": false, "pii": "S0168827811608222", "authors": {"author": [{"$": "M. Welker"}, {"$": "W. P. Hofmann"}, {"$": "B. Kronenberger"}]}}, {"@_fa": "true", "load-date": "2016-02-26T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0031302516311552"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0031302516311552?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1097/01.PAT.0000454259.31128.90", "prism:url": "https://api.elsevier.com/content/article/pii/S0031302516311552", "dc:title": "Pathological and virological examinations of enterovirus 71 infection: an autopsy case", "dc:creator": "Lu Lu Gao", "prism:publicationName": "Pathology", "prism:volume": "46", "prism:coverDate": "2014-12-31", "prism:startingPage": "s47", "prism:doi": "10.1097/01.PAT.0000454259.31128.90", "openaccess": false, "pii": "S0031302516311552", "authors": {"author": [{"$": "Lu Lu Gao"}, {"$": "Pei Xin Lin"}, {"$": "Hong Shen"}]}}, {"@_fa": "true", "load-date": "2013-04-25T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827813608326"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827813608326?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(13)60832-6", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827813608326", "dc:title": "830 CHOLESTEROL LEVELS AND PRESENCE OF DIABETES PREDICT EARLY VIROLOGICAL RESPONSE TO TRIPLE THERAPY WITH TELAPREVIR, PEG-INTERFERON alfa-2a 180 \u03bcg AND RIBAVIRIN IN CHRONIC HEPATITIS C", "dc:creator": "E. Jaeckel", "prism:publicationName": "Journal of Hepatology", "prism:volume": "58", "prism:coverDate": "2013-04-30", "prism:startingPage": "s340", "prism:doi": "10.1016/S0168-8278(13)60832-6", "openaccess": false, "pii": "S0168827813608326", "authors": {"author": [{"$": "E. Jaeckel"}, {"$": "E. Zehnter"}, {"$": "M. P. Manns"}]}}, {"@_fa": "true", "load-date": "2012-04-23T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827812609192"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827812609192?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(12)60919-2", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827812609192", "dc:title": "907 LOW VITAMIN D SERUM LEVELS ARE ASSOCIATED WITH LIVER FIBROSIS AND IMPAIRED VIROLOGIC RESPONSE TO ANTIVIRAL THERAPY WITH PEGIFN+RBV IN HIV/HCV COINFECTED PATIENTS", "dc:creator": "M. Mandorfer", "prism:publicationName": "Journal of Hepatology", "prism:volume": "56", "prism:coverDate": "2012-04-30", "prism:startingPage": "s353", "prism:doi": "10.1016/S0168-8278(12)60919-2", "openaccess": false, "pii": "S0168827812609192", "authors": {"author": [{"$": "M. Mandorfer"}, {"$": "T. Reiberger"}, {"$": "M. Peck-Radosavljevic"}]}}, {"@_fa": "true", "load-date": "2017-05-11T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827817308243"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827817308243?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(17)30824-3", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827817308243", "dc:title": "THU-157: Diversity of clinical presentation and virological characteristics of hepatitis delta in different regions world-wide: results of the Hepatitis Delta International network", "dc:creator": "A. Wranke", "prism:publicationName": "Journal of Hepatology", "prism:volume": "66", "prism:coverDate": "2017-12-31", "prism:startingPage": "s257", "prism:endingPage": "s258", "prism:doi": "10.1016/S0168-8278(17)30824-3", "openaccess": false, "pii": "S0168827817308243", "authors": {"author": [{"$": "A. Wranke"}, {"$": "S. Hardtke"}, {"$": "R. Fontana"}]}}, {"@_fa": "true", "load-date": "2011-04-18T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827811603000"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827811603000?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(11)60300-0", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827811603000", "dc:title": "298 SUSTAINED VIROLOGIC RESPONSE IN HIGH VIRAEMIC GENOTYPE-1 HCV INFECTION CORRELATES WITH PERIPHERAL HCV-SPECIFIC CYTOTOXIC RESPONSE RESTORATION", "dc:creator": "J. R. Larrubia", "prism:publicationName": "Journal of Hepatology", "prism:volume": "54", "prism:coverDate": "2011-03-31", "prism:startingPage": "s121", "prism:doi": "10.1016/S0168-8278(11)60300-0", "openaccess": false, "pii": "S0168827811603000", "authors": {"author": [{"$": "J. R. Larrubia"}, {"$": "S. Benito"}, {"$": "T. Parra-Cid"}]}}, {"@_fa": "true", "load-date": "2010-04-13T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827810602681"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827810602681?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(10)60268-1", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827810602681", "dc:title": "266 CLINICAL MARKERS OF THE METABOLIC SYNDROME ARE ASSOCIATED WITH HCV GENOTYPE 1 INFECTION AND ARE STRONG NEGATIVE PREDICTORS OF EARLY VIROLOGICAL RESPONSE", "dc:creator": "E. Jaeckel", "prism:publicationName": "Journal of Hepatology", "prism:volume": "52", "prism:coverDate": "2010-04-30", "prism:startingPage": "s112", "prism:doi": "10.1016/S0168-8278(10)60268-1", "openaccess": false, "pii": "S0168827810602681", "authors": {"author": [{"$": "E. Jaeckel"}, {"$": "E. Zehnter"}, {"$": "M. P. Manns"}]}}, {"@_fa": "true", "load-date": "2013-04-25T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827813608223"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827813608223?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(13)60822-3", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827813608223", "dc:title": "820 THERAPEUTIC DRUG MONITORING OF TELAPREVIR IN CHRONIC HEPATITIS C PATIENTS RECEIVING TELAPREVIR-BASED TRIPLE THERAPY IS USEFUL FOR PREDICTING VIROLOGICAL RESPONSE AND AVOIDING TOXIC DRUG-EXPOSURE", "dc:creator": "N. Furusyo", "prism:publicationName": "Journal of Hepatology", "prism:volume": "58", "prism:coverDate": "2013-04-30", "prism:startingPage": "s336", "prism:doi": "10.1016/S0168-8278(13)60822-3", "openaccess": false, "pii": "S0168827813608223", "authors": {"author": [{"$": "N. Furusyo"}, {"$": "E. Ogawa"}, {"$": "J. Hayashi"}]}}, {"@_fa": "true", "load-date": "2013-04-25T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827813608624"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827813608624?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(13)60862-4", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827813608624", "dc:title": "860 REVISTING PREDICTORS OF VIROLOGIC RESPONSE TO PEGIFN+RBV THERAPY IN HIV/HCV COINFECTED PATIENTS: THE ROLE OF METABOLIC FACTORS AND ELEVATED GGT LEVELS", "dc:creator": "M. Mandorfer", "prism:publicationName": "Journal of Hepatology", "prism:volume": "58", "prism:coverDate": "2013-04-30", "prism:startingPage": "s352", "prism:endingPage": "s353", "prism:doi": "10.1016/S0168-8278(13)60862-4", "openaccess": false, "pii": "S0168827813608624", "authors": {"author": [{"$": "M. Mandorfer"}, {"$": "T. Reiberger"}, {"$": "M. Peck-Radosavljevic"}]}}, {"@_fa": "true", "load-date": "2010-04-13T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827810602929"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827810602929?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(10)60292-9", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827810602929", "dc:title": "290 EARLY VIROLOGICAL RESPONSE PROFILES WITH TELAPREVIR (T) IN COMBINATION WITH PEGINTERFERON-ALFA-2A (P) AND RIBAVIRIN (R) IN GENOTYPE 1 HCV TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS ARE SIMILAR", "dc:creator": "F. Poordad", "prism:publicationName": "Journal of Hepatology", "prism:volume": "52", "prism:coverDate": "2010-04-30", "prism:startingPage": "s121", "prism:endingPage": "s122", "prism:doi": "10.1016/S0168-8278(10)60292-9", "openaccess": false, "pii": "S0168827810602929", "authors": {"author": [{"$": "F. Poordad"}, {"$": "J. G. McHutchison"}, {"$": "N. Adda"}]}}, {"@_fa": "true", "load-date": "2011-04-18T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827811600123"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827811600123?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(11)60012-3", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827811600123", "dc:title": "10 POTENTIAL ENHANCEMENT OF BOTH EARLY (EVR) AND SUSTAINED (SVR) VIROLOGICAL RESPONSE BY FLUVASTATIN IN CHRONIC HEPATITIS C TREATED WITH STANDARD PEGIFN-RIBAVIRIN THERAPY. A PILOT STUDY", "dc:creator": "E. F. Georgescu", "prism:publicationName": "Journal of Hepatology", "prism:volume": "54", "prism:coverDate": "2011-03-31", "prism:startingPage": "s5", "prism:doi": "10.1016/S0168-8278(11)60012-3", "openaccess": false, "pii": "S0168827811600123", "authors": {"author": [{"$": "E. F. Georgescu"}, {"$": "L. Streba"}, {"$": "M. Tataru Abagiu"}]}}, {"@_fa": "true", "load-date": "2013-04-25T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0168827813608338"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0168827813608338?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/S0168-8278(13)60833-8", "prism:url": "https://api.elsevier.com/content/article/pii/S0168827813608338", "dc:title": "831 DELAYED DECLINE OF ON-TREATMENT HEMOGLOBIN WAS ASSOCIATED WITH BETTER SUSTAINED VIROLOGICAL RESPONSES IN GENOTYPE-2 CHRONIC HEPATITIS C PATIENTS RECEIVING PEG-IFN/RBV TREATMENT", "dc:creator": "W. -J. Jeng", "prism:publicationName": "Journal of Hepatology", "prism:volume": "58", "prism:coverDate": "2013-04-30", "prism:startingPage": "s340", "prism:endingPage": "s341", "prism:doi": "10.1016/S0168-8278(13)60833-8", "openaccess": false, "pii": "S0168827813608338", "authors": {"author": [{"$": "W. -J. Jeng"}, {"$": "C. -Y. Lin"}, {"$": "I. -S. Sheen"}]}}, {"@_fa": "true", "load-date": "2005-03-01T00:00:00.000Z", "link": [{"@_fa": "true", "@ref": "self", "@href": "https://api.elsevier.com/content/article/pii/S0889855303001377"}, {"@_fa": "true", "@ref": "scidir", "@href": "https://www.sciencedirect.com/science/article/pii/S0889855303001377?dgcid=api_sd_search-api-endpoint"}], "dc:identifier": "DOI:10.1016/j.gtc.2003.12.003", "prism:url": "https://api.elsevier.com/content/article/pii/S0889855303001377", "dc:title": "Adherence to combination therapy: influence on sustained virologic response and economic impact", "dc:creator": "Michael P Manns", "prism:publicationName": "Gastroenterology Clinics of North America", "prism:volume": "33", "prism:coverDate": "2004-03-31", "prism:startingPage": "11", "prism:endingPage": "24", "prism:doi": "10.1016/j.gtc.2003.12.003", "openaccess": false, "pii": "S0889855303001377", "authors": {"author": "Michael P Manns"}}]